Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes

NCT01220622 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

656

Enrollment

OTHER_GOV

Sponsor class

Conditions

Stroke
Mild Cognitive Impairment

Interventions

DRUG: Nimodipine
DRUG: Placebo

Sponsor

Ministry of Science and Technology of the People´s Republic of China